Cargando…

Fusobacterium nucleatum and cancer

Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is involved in the progression of an increasing number of tumors types. Thus far, the mechanisms underlying tumor exacerbation by F. nucleatum include the enhancement of proliferation, establishment of a tumor‐promot...

Descripción completa

Detalles Bibliográficos
Autores principales: Alon‐Maimon, Tamar, Mandelboim, Ofer, Bachrach, Gilad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315032/
https://www.ncbi.nlm.nih.gov/pubmed/35244982
http://dx.doi.org/10.1111/prd.12426
_version_ 1784754462412242944
author Alon‐Maimon, Tamar
Mandelboim, Ofer
Bachrach, Gilad
author_facet Alon‐Maimon, Tamar
Mandelboim, Ofer
Bachrach, Gilad
author_sort Alon‐Maimon, Tamar
collection PubMed
description Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is involved in the progression of an increasing number of tumors types. Thus far, the mechanisms underlying tumor exacerbation by F. nucleatum include the enhancement of proliferation, establishment of a tumor‐promoting immune environment, induction of chemoresistance, and the activation of immune checkpoints. This review focuses on the mechanisms that mediate tumor‐specific colonization by fusobacteria. Elucidating the mechanisms mediating fusobacterial tumor tropism and promotion might provide new insights for the development of novel approaches for tumor detection and treatment.
format Online
Article
Text
id pubmed-9315032
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-93150322022-07-30 Fusobacterium nucleatum and cancer Alon‐Maimon, Tamar Mandelboim, Ofer Bachrach, Gilad Periodontol 2000 Review Articles Accumulating evidence demonstrates that the oral pathobiont Fusobacterium nucleatum is involved in the progression of an increasing number of tumors types. Thus far, the mechanisms underlying tumor exacerbation by F. nucleatum include the enhancement of proliferation, establishment of a tumor‐promoting immune environment, induction of chemoresistance, and the activation of immune checkpoints. This review focuses on the mechanisms that mediate tumor‐specific colonization by fusobacteria. Elucidating the mechanisms mediating fusobacterial tumor tropism and promotion might provide new insights for the development of novel approaches for tumor detection and treatment. John Wiley and Sons Inc. 2022-03-04 2022-06 /pmc/articles/PMC9315032/ /pubmed/35244982 http://dx.doi.org/10.1111/prd.12426 Text en © 2022 The Authors. Periodontology 2000 published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Articles
Alon‐Maimon, Tamar
Mandelboim, Ofer
Bachrach, Gilad
Fusobacterium nucleatum and cancer
title Fusobacterium nucleatum and cancer
title_full Fusobacterium nucleatum and cancer
title_fullStr Fusobacterium nucleatum and cancer
title_full_unstemmed Fusobacterium nucleatum and cancer
title_short Fusobacterium nucleatum and cancer
title_sort fusobacterium nucleatum and cancer
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9315032/
https://www.ncbi.nlm.nih.gov/pubmed/35244982
http://dx.doi.org/10.1111/prd.12426
work_keys_str_mv AT alonmaimontamar fusobacteriumnucleatumandcancer
AT mandelboimofer fusobacteriumnucleatumandcancer
AT bachrachgilad fusobacteriumnucleatumandcancer